Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,719 public trials 1,764 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Recruiting

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

NCT06726148

Conditions
Advanced CCNE1-amplified Solid Tumors, Advanced HR+/HER2- Breast Cancer, Breast Diseases, +14 more
Locations
  • University of California LA Los Angeles, California, United States
  • Florida Cancer Specialists Fort Myers, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • WA Uni School Of Med St Louis, Missouri, United States
View all 33 locations
View Trial Details
Recruiting

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

NCT07100106

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope - Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • UCSF Helen Diller Family CCC San Francisco, California, United States
View all 52 locations
View Trial Details
Recruiting

A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation

NCT05877599

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +47 more
Locations
  • Research Site Gilbert, Arizona, United States
  • Research Site Duarte, California, United States
  • Research Site Newport Beach, California, United States
  • Research Site Santa Monica, California, United States
View all 18 locations
View Trial Details
Recruiting

Pembrolizumab + Paclitaxel +/- Bevacizumab for Triple-negative Breast Cancer

NCT06976944

Conditions
Breast Diseases, Breast Neoplasms, Neoplasms, +5 more
Locations
  • National Hospital Organization Nagoya Medical Center Nagoya, Aichi-ken, Japan
  • Nagoya University Hospital Nagoya, Aichi-ken, Japan
  • Nagoya City University Hospital Nagoya, Aichi-ken, Japan
  • National Cancer Center Hospital East Kashiwa-shi, Chiba, Japan
View all 14 locations
View Trial Details

Related conditions